MDMA Investigator’s Brochure
Our Investigator’s Brochure for MDMA researchers describes the physical, chemical, and pharmacological characteristics of MDMA, its effects in nonclinical and clinical studies, and the safety profile of MDMA-assisted psychotherapy. This brochure focuses on research and information relevant to researchers and regulators engaged in clinical trials with MDMA.
- Download the MDMA Investigator’s Brochure (13th Edition: March 22, 2021)
Note: The navigation links in this document work best with Adobe Reader or Google Chrome.
For past editions of the Investigator’s Brochure, see the MDMA Literature Review.
Development Safety Update Report on MDMA
This report covers clinical, nonclinical, and manufacturing research updates from the MDMA Clinical Development Program sponsored by MAPS or MAPS Europe B.V. through October 1 of each year. This report was prepared and submitted by the MAPS Public Benefit Corporation (MAPS PBC).
- 2020 Development Safety Update Report on MDMA (Version: December 11, 2020)